These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34916687)

  • 1. [Clinical and immunological characteristics of 88 cases of overlap myositis].
    Xiao YS; Zhu FY; Luo L; Xing XY; Li YH; Zhang XW; Shen DH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1088-1093. PubMed ID: 34916687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of anti-Jo-1 antibody's clinical stratification in idiopathic inflammatory myopathy and disease spectrum].
    Li JC; Lai ZH; Shao M; Jin YB; Gao XJ; Zhang K; Hou J; Zhang YY; Li ZG; Li YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):958-965. PubMed ID: 38101775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and immunological characteristics of myositis complicated with thromboembolism].
    Zhu FY; Xing XY; Tang XF; Li YM; Shao M; Zhang XW; Li YH; Sun XL; He J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):995-1000. PubMed ID: 33331304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease.
    Cobo-Ibáñez T; López-Longo FJ; Joven B; Carreira PE; Muñoz-Fernández S; Maldonado-Romero V; Larena-Grijalba C; Cubas IL; Muriel ET; Mateos CB; de la Peña Lefebvre PG; Gomez-Gomez A; Nogal LB; Pérez A; Almodovar R; Lojo L; Ruiz-Gutiérrez L; López-Robledillo JC; García de Yébenes MJ; Nuño-Nuño L
    Clin Rheumatol; 2019 Mar; 38(3):803-815. PubMed ID: 30392161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
    [No Abstract]   [Full Text] [Related]  

  • 8. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
    Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
    Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study.
    Xing X; Gan Y; Mo W; Zhang J; Wang N; Zhang K; Ma K; Zhang L; Ma L; Lu D; Li Y; He J
    Clin Rheumatol; 2024 Mar; 43(3):1145-1154. PubMed ID: 38326675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort.
    Naveen R; Rathore U; Agarwal V; Gupta L
    Rheumatol Int; 2021 Mar; 41(3):551-563. PubMed ID: 33423071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
    Zhang D; Wang H; Zhou X; Yang J; Liu Y; Wang W; Jiang P; Fan B
    Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy.
    Soubrier C; Seguier J; Di Costanzo MP; Ebbo M; Bernit E; Jean E; Veit V; Swiader L; Salort-Campana E; Attarian S; De Paula AM; Kaplanski G; Durand JM; Harlé JR; Schleinitz N
    Clin Rheumatol; 2019 Dec; 38(12):3451-3458. PubMed ID: 31440919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies].
    Lai Z; Li J; Yun Z; Zhang Y; Zhang H; Xing X; Shao M; Jin Y; Wang N; Li Y; Li Y; Li Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):284-292. PubMed ID: 38595246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and immunological characteristics of patients with anti-synthetase syndrome complicated with cardiac involvement].
    Luo L; Xing XY; Xiao YS; Chen KY; Zhu FY; Zhang XW; Li YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1078-1082. PubMed ID: 34916685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry.
    Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Llorente Cubas I; Tomero E; Barbadillo-Mateos MC; García de la Peña Lefebvre P; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; García de Yébenes MJ; López-Longo FJ
    Int J Rheum Dis; 2019 Aug; 22(8):1393-1401. PubMed ID: 30968571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies.
    Rams A; Kosałka-Węgiel J; Kuszmiersz P; Matyja-Bednarczyk A; Polański S; Zaręba L; Bazan-Socha S
    Adv Clin Exp Med; 2021 Dec; 30(12):1239-1248. PubMed ID: 34610217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.